期刊文献+

银屑病患者皮损中磷脂酰肌醇3激酶过表达 被引量:4

Up-regulation of Expression of Phosphatidylinositol 3-kinase in Psoriatic Lesions
原文传递
导出
摘要 目的探讨磷脂酰肌醇3激酶(PI3激酶)与银屑病发病的相关性。方法应用点杂交、原位杂交和免疫组化的方法,分析了12例寻常型银屑病患者皮损区和5例正常人表皮中PI3激酶表达分布特点。结果银屑病皮损中PI3激酶mRNA和蛋白的表达较正常人皮肤明显增强,银屑病患者与正常人皮肤中PI3激酶基因与蛋白的表达一致。结论银屑病皮损中PI3激酶过表达可能与银屑病角质形成细胞的过度增殖相关。 Objective To investigate the correlation between phosphatidylinositol 3 kinase (PI3-kinase) and the pathogenesis of psoriasis. Methods By dot hybridization, in situ hybridization and immunohistochemistry, expression of PI3 kinase was observed in twelve psoriatic and five normal epidermis. Results In psoriatic epidermis, expression of PI3 kinase gene and protein was elevated obviously compared with that of normal skin. Conclusion PI3 kinase may be closely associated with hyperproliferation of psoriatic keratinocytes.
出处 《中华皮肤科杂志》 CAS CSCD 北大核心 2002年第2期97-98,共2页 Chinese Journal of Dermatology
基金 国家自然科学基金资助课题(9388002)
关键词 银屑病 皮损 磷脂酰肌醇3激酶 过表达 角质形成细胞 细胞过度增殖 Psoriasis 1 Phosphatidylinositol 3 kinase
  • 相关文献

参考文献9

  • 1Rhee SG. Inositol phospholipid- specific phospholipase C: interaction of the gamma 1 isoform with tyrosine kinase. Trends Biochem Sci, 1991, 16:297- 301.
  • 2Cantley LC, Auger KR, Carpenter C, et al. Oncogenes and signal transduction. Cell, 1991, 64:281- 302.
  • 3Ling LE, Druker BT, Cantley LC, et al. Transformation- defective mutants of polyomavirus middle T antigen associate with phosphatidylinositol 3- kinase (PI 3- kinase) but are unable to maintain wild- type levels of PI 3- kinase products in intact cells. J Virol, 1992, 66:1702- 1708.
  • 4Shambrook J, Fritsch EF, Maniatis T, et al. Molecular Cloning- A Laboratory Manual. Cold Harbor Laboratory Press, 2nd,1989.
  • 5张晓艳,马圣清,柳惠图.周期蛋白依赖激酶抑制因子p21^(WAF1/CIP1)在银屑病表皮中高表达[J].中华皮肤科杂志,1998,31(6):363-365. 被引量:2
  • 6张晓艳,马圣清,柳惠图.反义蛋白激酶Cζ对角质形成细胞增殖的影响[J].中华皮肤科杂志,1999,32(2):77-79. 被引量:3
  • 7Ullrich A, Schlessinger J. Signal transduction by receptors with tyrosine kinase activity. Cell, 1990,61:203- 212.
  • 8Bjorge JD, Chan TO, Antczak M, et al. Activated typeⅠ phosphatidylinositol kinase is associated with the epidermal growth factor(EGF) receptor following EGF stimulation. Proc Natl Acad Sci USA,1990,87:3816- 3820.
  • 9Xu S, Cwyfan- Hughes SC, Van der Stappen JW, et al. Altered insulin- like growth factor- Ⅱ (IGF- Ⅱ ) level and IGF- binding protein- 3(IGFBP- 3) protease activity in interstitial fluid taken from the skin lesion of psoriasis. J Invest Dermatol, 1996,106:109- 112.

二级参考文献2

  • 1Jiang H,Oncogene,1994年,9卷,3387页
  • 2Xiong Y,Nature,1993年,366卷,70页

共引文献3

同被引文献22

  • 1周颖,王建,贺福初.蛋白激酶B(PKB/Akt)的结构、调控与功能[J].生命的化学,2006,26(3):226-228. 被引量:12
  • 2Wymann MP, Zvelebil M, Laffargue M. Phosphoinositide 3- kinase signaling--which way to target? Trends Pharmacol Sci, 2003, 24(7): 366-376.
  • 3Cantley LC. The phosphoinositide 3-kinase pathway. Science, 2002, 296(5573): 1655-1657.
  • 4Fabre S, Lang V, Harriague J, et al. Stable activation of phospha- tidylinositol 3-kinase in the T cell immtmological synapse stimulates Akt signaling to FoxO1 nuclear exclusion and cell growth control. J Immunol, 2005, 174(7): 4161-4171.
  • 5Philp AJ, Campbell IG, Leet C, et al. The phosphatidylinositol 3'- kinase p85 alpha gene is an oncogene in human ovarian and colon tumors. Cancer Res, 2001, 61(20): 7426-7429.
  • 6Terragni J, Graham JR, Adams KW, et al. Phosphatidylinositol 3-kinase signaling in proliferating cel!s maintains an antiapoptotic transcriptional program mediated by inhibition of FOXO and non-canonical activation of NF kappaB transcription factors. BMC Cell Biol, 2008, 9: 6.
  • 7Cantley LC. The phosphoinositide 3-kinase pathway. Science, 2002, 296(5573): 1655-1657.
  • 8Pareellier A, Tintignac LA, Zhuravleva E, et al. PKB and the mitochondria: AKTing on apoptosis. Cell Signal, 2008, 20 (1): 21-30.
  • 9Shtilbans V, Wu M, Burstein DE. Current overview of the role of Akt in cancer studies via applied immunohistochemistry. Ann Diagn Pathol, 2008, 12(2): 153-160.
  • 10Xu S, Cwyfan-Hughes SC, van der Stappen JW, et al. Altered insulin-like growth factor-II (IGF-II) level and IGF-binding protein-3 (IGFBP-3) protease activity in interstitial fluid taken from the skin lesion of psoriasis. J Invest Dermatol, 1996, 106 (1): 109-112.

引证文献4

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部